Den Europæiske Union - estisk - EMA (European Medicines Agency)

advanced accelerator applications - l-arginine hydrochloride, l-lysine hydrochloride - kiirguse vigastused - detoxifying agents for antineoplastic treatment - lysakare on näidustatud vähendamine neeru-kiirgusega kokkupuute ajal peptiid-retseptori radionukliidide ravi (prrt) koos lutetium (177lu) oxodotreotide täiskasvanutel.

Estland - estisk - Ravimiamet

sanofi pasteur - marutõve koguviirus, inaktiveeritud - süstesuspensiooni pulber ja lahusti - 1annus 10tk; 1annus 1tk; 1annus 5tk

Estland - estisk - Ravimiamet

pharmaswiss ceska republika s.r.o. - zoledroonhape - infusioonilahus - 4mg 100ml 100ml 4tk; 4mg 100ml 100ml 10tk; 4mg 100ml 100ml 1tk

Estland - estisk - Ravimiamet

bayer animal health gmbh - toltrasuriil - suukaudne suspensioon - 50mg 1ml 100ml 1tk

Estland - estisk - Ravimiamet

glaxo wellcome uk limited - permetriin - kreem - 50mg 1g 30g 1tk

Estland - estisk - Ravimiamet

ceva-phylaxia zrt. - lindude nakkava bursiidi (gumboro) viirusvaktsiin - süstesuspensiooni kontsentraat ja lahusti - 8000annus 1tk; 2000annus 1tk; 4000annus 1tk

Den Europæiske Union - estisk - EMA (European Medicines Agency)

intervet international b.v. - cell-associated live recombinant turkey herpesvirus (strain hvt/ndv/ilt) expressing the fusion protein of newcastle disease virus and the glycoproteins gd and gi of infectious laryngotracheitis virus - immunoloogilised ained - embryonated chicken eggs; chicken - for active immunisation of one-day-old chicks or embryonated chicken eggs:to reduce mortality and clinical signs caused by newcastle disease (nd) virus,to reduce mortality, clinical signs and lesions caused by avian infectious laryngotracheitis (ilt) virus and marek’s disease (md) virus.

Den Europæiske Union - estisk - EMA (European Medicines Agency)

zoetis belgium sa - frunevetmab - valuvaigistid - kassid - for the alleviation of pain associated with osteoarthritis in cats.

Estland - estisk - Ravimiamet

zentiva k.s. - oseltamiviir - kõvakapsel - 75mg 10tk

Den Europæiske Union - estisk - EMA (European Medicines Agency)

roche registration gmbh  - casirivimab, imdevimab - covid-19 virus infection - suguhormoonid ja immunoglobuliinid, - ronapreve is indicated for:treatment of covid-19 in adults and adolescents aged 12 years and older weighing at least 40 kg who do not require supplemental oxygen and who are at increased risk of progressing to severe covid-19 (see section 4. prevention of covid-19 in adults and adolescents aged 12 years and older weighing at least 40 kg (see section 4. the use of ronapreve should take into account information on the activity of ronapreve against viral variants of concern. vt lõigud 4. 4 ja 5.